How do organizations best ensure a resilient cyber ecosystem–from assessing risk to implementing and managing controls to ensuring compliance internally and with external partners? Is it possible for defensive technologies to catch up and move ahead of attackers?
Join us at CyberSecure, our inaugural virtual event on the business of cyber risk, to hear how smart companies are striking preemptively, and what emerging technologies are proven to support smart security.
- Best Practices to Mitigate Cyber Risk from the Front Lines
This session presents a compilation of tactics designed to mitigate cyber risk across the public and private sectors–from implementing security best practices in the White House to establishing a network of intelligence for a leading financial institution.
Featuring: Alissa Abdullah (Dr. Jay), Deputy Chief Security Officer, Mastercard
- Phishing, Phones, and the New Social Engineering Threat
How does spear phishing gain access to mobile devices, what makes them so vulnerable to attack, and what can be done about it?
Featuring: Aaron Cockerill, Chief Strategy Officer, Lookout
- On the Tradeoffs Among Complexity, Functionality, and Security
Complexity is the enemy of security. Yet the complexity of the systems we deploy inexorably rises over time as software eats the world. Why is this the case and what can be done about it?
Featuring: Herbert Lin, Senior Research Scholar, Stanford University Center for International Security and Cooperation
Register today and we’ll see you virtually in December.
Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.